In vitro drug release testing of controlled release veterinary drug products
暂无分享,去创建一个
Michael J. Rathbone | Colin Roger Ogle | Shane Burggraaf | Jingjian Shen | Craig R. Bunt | M. Rathbone | C. Bunt | C. R. Ogle | S. Burggraaf | J. Shen
[1] S. Qureshi,et al. Application of flow-through dissolution method for the evaluation of oral formulations of nifedipine , 1994 .
[2] M. Gibaldi,et al. Solubilization and rate of dissolution of drugs in the presence of physiologic concentrations of lysolecithin. , 1967, Journal of pharmaceutical sciences.
[3] D. J. Stelzer,et al. Deaeration Techniques For Dissolution Media , 1995 .
[4] M. Siewert. FIP Guidelines for Dissolution Testing of Solid Oral Products (Final Draft, 1995) , 1996 .
[5] J. W. Skoug,et al. Strategy for the development and validation of dissolution tests for solid oral dosage forms , 1996 .
[6] I. Khan,et al. Dissolution testing for sustained or controlled release oral dosage forms and correlation with in vivo data: Challenges and opportunities , 1996 .
[7] L. Lesko,et al. Current Challenges and Future Regulatory Directions in In Vitro Dissolution , 1995 .
[8] Vinod P. Shah,et al. In vitro dissolution of sparingly water-soluble drug dosage forms , 1995 .
[9] W. Higuchi,et al. Dissolution kinetics of cholesterol in simulated bile I: Influence of bile acid type and concentration, bile acid-lecithin ration, and added electrolyte. , 1977, Journal of pharmaceutical sciences.
[10] C. D. Lathia,et al. Advances in Dissolution Technology: Design, Pros and Cons , 1986 .
[11] M. Gibaldi,et al. Rate of Dissolution of Griseofulvin and Hexoestrol in Bile Salt Solutions , 1966, Nature.
[12] M. Gibaldi,et al. Solubilizing properties of bile salt solutions. II. Effect of inorganic electrolyte, lipids, and a mixed bile salt system on solubilization of glutethimide, griseofulvin, and hexestrol. , 1966, Journal of pharmaceutical sciences.
[13] F. Langenbucher. in vitroとin vivoの薬物利用率を関連づける手段としての数字であらわしたコンボルューションとデコンボルューション , 1982 .
[14] G. R. Dukes,et al. SPECIFICATION DEVELOPMENT AND STABILITY ASSESSMENT , 1998 .
[15] I. Kanfer,et al. Level a in Vitro/in Vivo Correlations: A Quality Control Tool or Bioequivalence Predictor for Extended-Release Solid Oral Dosage Forms? , 1995 .
[16] C. E. Wells. Effect of sampling probe size on dissolution of tableted drug samples. , 1981, Journal of pharmaceutical sciences.
[17] W. Higuchi,et al. Mechanistic study of the influence of micelle solubilization and hydrodynamic factors on the dissolution rate of solid drugs. , 1968, Journal of pharmaceutical sciences.
[18] B. Rohrs,et al. USP dissolution apparatus 3 (reciprocating cylinder): instrument parameter effects on drug release from sustained release formulations. , 1995, Journal of pharmaceutical sciences.
[19] P. Welling,et al. In Vitro-in Vivo Correlations — Quo Vadis , 1995 .
[20] Lewis J. Leeson,et al. In Vitro/In Vivo Correlations , 1995 .
[21] E. Jorgensen,et al. Development of dissolution tests for oral extended-release products , 1998 .
[22] H. Möller,et al. Regulatory aspects of modified release dosage forms: special cases of dissolution testing using the flow-through system. , 1993, Bollettino chimico farmaceutico.
[23] S. Ugwu,et al. New and Extended Applications for USP Drug Release Apparatus 3. , 1997 .
[24] C. E. Wells,et al. Automated sampling of in vitro dissolution medium: effect of sampling probes on dissolution rate of prednisone tablets. , 1982, Journal of pharmaceutical sciences.
[25] N. Gochman,et al. Effect of a detergent on gastrointestinal absorption of a steroid. , 1961, Lancet.